Women in AI
Emmanuelle Charpentier & Jennifer Doudna
Nobel Prize-winning CRISPR Pioneers
Emmanuelle Charpentier and Jennifer Doudna shared the 2020 Nobel Prize in Chemistry for their discovery and development of CRISPR-Cas9, a revolutionary gene-editing technology that allows scientists to precisely modify DNA sequences in living organisms.
Jennifer Doudna is a professor of Chemistry and Molecular and Cell Biology at the University of California, Berkeley, and the founder of the Innovative Genomics Institute. Emmanuelle Charpentier is the founding director of the Max Planck Unit for the Science of Pathogens in Berlin.
Their groundbreaking 2012 paper demonstrated that the CRISPR-Cas9 system, originally a bacterial immune defense mechanism, could be reprogrammed to cut specific DNA sequences — essentially creating a molecular 'scissors' for the genome. This discovery has transformed biology and medicine, enabling precise genetic modifications for drug development, disease treatment, agricultural innovation, and basic research.
AI is now widely used to optimize CRISPR applications, including predicting guide RNA efficiency, identifying off-target effects, and designing complex genetic circuits.
